Ercem Atillasoy, MD
Chief Regulatory and Safety Officer; Senior Vice President, Research and Development, Jazz Pharmaceuticals
Jazz Pharmaceuticals•Greater Philadelphia, United States
View LinkedIn ProfileExperience30+ Years
LevelCXO
Executive Overview
Biopharmaceutical executive with 25+ years of experience leading global drug, biologic, cell therapy and vaccine product development. Career focused on developing and leading groups and organizations of Professionals, Physicians and/or Regulatory and Safety Scientists. Proven Track Record in Infectious Disease; Oncology; Vaccines; Dermatology; Cell Therapies; Gene Therapy; DNA/RNA platform Technologies. Expertise in Regulatory Affairs, Clinical Safety, Business Development and Licensing, Global Product Labeling, and Medical Affairs.
Career Timeline
- Jazz PharmaceuticalsCurrentOct 2022–Present· 4 yrs
- Chief Regulatory and Safety Officer and Senior Vice President, Research and DevelopmentCurrentOct 2022–Present
- Jul 2020–Oct 2022· 2 yrs 3 mos
- Chief Regulatory and Safety OfficerJul 2020–Oct 2022
- 2019–Jun 2025· 6 yrs 5 mos
- Industry Representative to the Dermatologic and Ophthalmologic Drugs Advisory Committee (P/A)2019–Jun 2025
- 2001–2020· 19 yrs
- Vice President2012–2020
- Executive Director2007–2012
- Senior Director2003–2007
- Director, Information Technology2001–2003
- 1996–2001· 5 yrs
- Director, Medical1996–2001
Education
Medical Internship
Yale New-Haven Hospital and Yale University School of Medicine, Dept. of Internal MedicineGRE
Dermatology Residency Program
University of PennsylvaniaDoctor of Medicine - MD
Medicine
Yale School of MedicineExecutive Relationship Map
Reports To
Ercem Atillasoy, MD
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer
Skills & Expertise
English LiteratureMedical AffairsProduct DevelopmentOncologyCell and Gene TherapyGeneral Medicine and CVClinical ResearchGlobal Regulatory AffairsResearch and Development (R&D)Infectious DiseasesDermatologyRX Advertising and PromotionProduct LabelingVaccines and Infectious DiseaseClinical Safety and PharmacovigilanceConsumer ProductsU.S. Food and Drug Administration (FDA)Business DevelopmentMolecular BiologyNeuropsychiatry